after splenectomy and requirements fell to 16 units PZI. In May 1963, Investigations: Urine 17-OS 7 mg/24 hours. The excretion of gonadotrophin was 30 mg International Reference Preparation Human Menopausal Gonadotrophin (IRP-HMG)/24 hours by uterine weight assay (i.e. upper normal level).
Buccal smears showed no Barr bodies. Testicular biopsy showed small seminiferous tubules with spermatogonia but there was no evidence of spermatogenesis or Leydig cells. Skull X-ray and tests of pituitary, thyroid and adrenal cortex function gave normal results.
Treatment: Injections of human pituitary Follicle Stimulating Hormone (FSH), each injection equivalent to 600 mg IRP-HMG, were given three times a week from April to August 1964, causing increase in testicular size, with enlargement of tubules. FSH injections, each equivalent to 2,000 mg IRP-HMG, from August to October produced a further increase in testicular size. No Leydig cells could be seen in biopsies taken in August and October. Human chorionic gonadotrophin (HCG) 12,000 units, was added to each injection of FSH from October 1964 to February 1965. During this period 17-OS excretion rose to 25 mg/24 hours and finally to 66 mg; the excretion of cestriol was 25 Ig/24 hours, rising to 49 ,ug; body weight increased 13 kg; muscular development was evident and facial hair increased. The testes now measure 30 x 20 mm. The first nocturnal emission occurred after three injections of both hormones. Testicular biopsy in February showed a few spermatozoa lying in dilated tubules and nests of Leydig cells were prominent. In March spermatozoa appeared in ejaculates, the count being one million per ml.
The following case was also shown:
Islet Cell Carcinoma of the Pancreas Dr J R Hearnshaw (for Dr J D N Nabarro)
